We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+12.31%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$33.4B
AUM Growth
+$2.35B
Cap. Flow
-$652M
Cap. Flow %
-1.96%
Top 10 Hldgs %
25.9%
Holding
1,133
New
72
Increased
394
Reduced
425
Closed
76

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$242M
2
AMZN icon
Amazon
AMZN
+$69.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$67M
4
UBS icon
UBS Group
UBS
+$59.2M
5
LW icon
Lamb Weston
LW
+$58.5M

Top Sells

Rank Stock Value
1
AXNX
Axonics, Inc. Common Stock
AXNX
+$105M
2
AAPL icon
Apple
AAPL
+$87.1M
3
APTV icon
Aptiv
APTV
+$80.3M
4
TSCO icon
Tractor Supply
TSCO
+$80M
5
DE icon
Deere & Co
DE
+$78.5M

Sector Composition

Rank Sector Weight
1 Technology 35.56%
2 Healthcare 16.52%
3 Consumer Discretionary 11.68%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
551
Humana
HUM
$47.6B
$4.57M 0.01%
13,195
-15,481
-54% -$5.87M
D icon
552
Dominion Energy
D
$56.2B
$4.57M 0.01%
92,884
-50,848
-35% -$2.38M
SPSC icon
553
SPS Commerce
SPSC
$2.95B
$4.55M 0.01%
24,607
-2,407
-9% -$444K
VAC icon
554
Marriott Vacations Worldwide
VAC
$3.48B
$4.54M 0.01%
42,100
FOUR icon
555
Shift4
FOUR
$3.34B
$4.53M 0.01%
68,496
-3,691
-5% -$278K
HII icon
556
Huntington Ingalls Industries
HII
$11B
$4.49M 0.01%
15,405
+13,858
+896% +$3.82M
TNL icon
557
Travel + Leisure Co
TNL
$4.01B
$4.47M 0.01%
91,332
-15,168
-14% -$648K
VRNA
558
DELISTED
Verona Pharma
VRNA
$4.47M 0.01%
277,784
+79
+0% +$1.37K
OPLN
559
Openlane
OPLN
$4.26B
$4.42M 0.01%
255,713
-26,925
-10% -$404K
CLS icon
560
Celestica
CLS
$40B
$4.42M 0.01%
98,300
JD icon
561
JD.com
JD
$36.6B
$4.4M 0.01%
160,579
-473,853
-75% -$11.6M
KYMR icon
562
Kymera Therapeutics
KYMR
$9.41B
$4.39M 0.01%
+109,217
New +$3.91M
RCUS icon
563
Arcus Biosciences
RCUS
$3.1B
$4.38M 0.01%
232,072
+63
+0% +$1.09K
WTS icon
564
Watts Water Technologies
WTS
$11.7B
$4.35M 0.01%
20,461
-1,248
-6% -$253K
TDC icon
565
Teradata
TDC
$2.73B
$4.35M 0.01%
112,425
+1,808
+2% +$76.2K
GEHC icon
566
GE HealthCare
GEHC
$28.9B
$4.34M 0.01%
47,776
-34,266
-42% -$2.85M
XFOR icon
567
X4 Pharmaceuticals
XFOR
$359M
$4.27M 0.01%
102,479
+28
+0% +$779
REXR icon
568
Rexford Industrial Realty
REXR
$8.61B
$4.27M 0.01%
84,826
-5,174
-6% -$274K
MPC icon
569
Marathon Petroleum
MPC
$115B
$4.2M 0.01%
20,861
-50,095
-71% -$8.57M
APTV icon
570
Aptiv
APTV
$9.08B
$4.2M 0.01%
52,768
-995,232
-95% -$80.3M
PGNY icon
571
Progyny
PGNY
$2.13B
$4.2M 0.01%
110,138
-919
-0.8% -$34.7K
DOCS icon
572
Doximity
DOCS
$4.6B
$4.15M 0.01%
154,400
-39,697
-20% -$1.13M
ROK icon
573
Rockwell Automation
ROK
$46.3B
$4.15M 0.01%
14,260
-33,963
-70% -$9.78M
CYRX icon
574
CryoPort
CYRX
$826M
$4.13M 0.01%
+233,362
New +$3.7M
BN icon
575
Brookfield
BN
$82.9B
$4.13M 0.01%
147,941
-115,773
-44% -$3.12M

Similar funds

Axa's Q1 2024 Portfolio in Review

As of Q1 2024, Axa held 1,133 positions worth $33.4B, up 7.6% from $31B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Axa's Q1 2024 filing shows 72 new, 394 increased, 425 reduced and 76 closed positions. Its largest new stake was Lamb Weston: 561,708 shares worth $59.8M. The largest sale was Axonics, Inc. Common Stock, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q1 2024 buy was Lamb Weston: 561,708 shares worth $59.8M.
  • Axa added most to Meta Platforms (Facebook) in Q1 2024, an estimated $242M increase.
  • Axa's biggest Q1 2024 reduction was Axonics, Inc. Common Stock, cutting an estimated $105M.
  • Axa fully exited Archer Daniels Midland in Q1 2024, selling an estimated $53.4M.
  • Axa's ten largest holdings make up 26% of its $33.4B portfolio in Q1 2024.
  • Axa opened 72 new positions and closed 76 in Q1 2024.
  • Axa's portfolio value rose 7.6% quarter-over-quarter to $33.4B.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.